Effect of Preexisting Serum and Mucosal Antibody on Experimental Respiratory Syncytial Virus (RSV) Challenge and Infection of Adults

Journal of Infectious Diseases

Volumn 212, Issue 10, 2015, Pages 1719-1725

  Bagga, Bindiya ^a,b   Cehelsky, Jeffrey E ^c   Vaishnaw, Akshay ^c   Tomwilkinson, T ^d   Meyers, Rachel ^c   Harrison, Lisa M ^a   Roddam, Philippa L ^a,b   Walsh, Edward E ^e   DeVincenzo, John P ^a,b,f  

^a LE BONHEUR CHILDREN'S MEDICAL CENTER   (United States)

^b LE BONHEUR CHILDREN S HOSPITAL   (United States)

^c ALNYLAM PHARMACEUTICALS   (United States)

^d UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^e UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^f UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Correlates of protection; Mucosal antibody responses; Respiratory syncytial virus; Serum antibody responses; Vaccines

Indexed keywords

IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; RESPIRATORY SYNCYTIAL VIRUS VACCINE; VIRUS ANTIBODY;

ADULT; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; COLONY FORMING UNIT; CONTROLLED STUDY; CORRELATION ANALYSIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN RESPIRATORY SYNCYTIAL VIRUS; IMMUNOGLOBULIN BLOOD LEVEL; MALE; MOLECULAR DYNAMICS; OPTICAL DENSITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RESPIRATORY SYNCYTIAL VIRUS INFECTION; VIRUS INFECTIVITY; VIRUS LOAD; VIRUS NEUTRALIZATION; VIRUS REPLICATION; VIRUS TITRATION; ADOLESCENT; BLOOD; IMMUNOLOGY; MIDDLE AGED; NOSE CAVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NASAL CAVITY; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; YOUNG ADULT;

EID: 84948435260     PISSN: 00221899     EISSN: 15376613     Source Type: Journal    
DOI: 10.1093/infdis/jiv281     Document Type: Article

References (15)

1. Mills JT, Van Kirk JE, Wright PF, Chanock RM. Experimental respiratory syncytial virus infection of adults. Possible mechanisms of resistance to infection and illness. J Immunol 1971; 107:123-30.
2. Falsey AR, Walsh EE. Relationship of serum antibody to risk of respiratory syncytial virus infection in elderly adults. J Infect Dis 1998; 177:463-6.
3. Walsh EE, Peterson DR, Falsey AR. Risk factors for severe respiratory syncytial virus infection in elderly persons. J Infect Dis 2004; 189:233-8.
4. DeVincenzo JP, Wilkinson T, Vaishnaw A, et al. Viral load drives disease in humans experimentally infected with respiratory syncytial virus. Am J Respir Crit Care Med 2010; 182:1305-14.
5. Kim YI, DeVincenzo JP, Jones BG, et al. Respiratory syncytial virus human experimental infection model: provenance, production, and sequence of low-passaged memphis-37 challenge virus. PLoS One 2014; 9:e113100.
6. Devincenzo JP. Natural infection of infants with respiratory syncytial virus subgroups A and B: A study of frequency, disease severity, and viral load. Pediatr Res 2004; 56:914-7.
7. Perkins SM, Webb DL, Torrance SA, et al. Comparison of a real-time reverse transcriptase PCR assay and a culture technique for quantitative assessment of viral load in children naturally infected with respiratory syncytial virus. J Clin Microbiol 2005; 43:2356-62.
8. Falsey AR, Singh HK,Walsh EE. Serum antibody decay in adults following natural respiratory syncytial virus infection. J Med Virol 2006; 78:1493-7.
9. McCullers JA, Huber VC. Correlates of vaccine protection from influenza and its complications. Hum Vaccin Immunother 2012; 8:34-44.
10. Barria MI, Garrido JL, Stein C, et al. Localized mucosal response to intranasal live attenuated influenza vaccine in adults. J Infect Dis 2013; 207:115-24.
11. Lee FE, Walsh EE, Falsey AR, Betts RF, Treanor JJ. Experimental infection of humans with A2 respiratory syncytial virus. Antiviral Res 2004; 63:191-6.
12. Walsh EE, Falsey AR. Humoral and mucosal immunity in protection from natural respiratory syncytial virus infection in adults. J Infect Dis 2004; 190:373-8.
13. Plotkin SA. Vaccines: correlates of vaccine-induced immunity. Clin Infect Dis 2008; 47:401-9.
14. Renegar KB, Small PA Jr, Boykins LG, Wright PF. Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract. J Immunol 2004; 173:1978-86.
15. Malley R, DeVincenzo J, Ramilo O, et al. Reduction of respiratory syncytial virus (RSV) in tracheal aspirates in intubated infants by use of humanized monoclonal antibody to RSV F protein. J Infect Dis 1998; 178:1555-61.